CALVIN SANDRA

PrivateCIK: 1882909
Location

SAN DIEGO, CA

CALVIN SANDRA (VP, Corp Controller and CAO) sold 34.2% of their position (21.98K shares) of TRAVERE THERAPEUTICS, INC. on the open market

Open‑market sale worth $902.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 1 sale
InsiderCALVIN SANDRACIK 1882909
Officer· VP, Corp Controller and CAO
Since Sep 2021
-21.98K
Net shares
Net seller
$902.6K
Total sold
1
Open market trades
0B · 1S
7
Total transactions
15.25K acquired · 37.23K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+2.50K

Price / share

$22.40

Trade value

$56K

% of position

5.1%
4/14/2026
49.08K51.58K

Common Stock

Direct
M · Option Exercise

Shares

+6.25K

Price / share

$8.93

Trade value

$55.81K

% of position

12.1%
4/14/2026
51.58K57.83K

Common Stock

Direct
M · Option Exercise

Shares

+6.50K

Price / share

$20.46

Trade value

$132.99K

% of position

11.2%
4/14/2026
57.83K64.33K

Common Stock

Direct
S · Sale

Shares

21.98K

Price / share

$41.07

Trade value

$902.60K

% of position

34.2%
4/14/2026
64.33K42.35K
Total

Net shares

6.73K

Net value

-$657.79K

Derivative Transactions3

Employee stock option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

2.50K shares

Shares

2.50K

Strike price

22.40

Held after

5K

Exercisable

4/14/2026

Employee stock option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

6.25K shares

Shares

6.25K

Strike price

8.93

Held after

12.50K

Exercisable

4/14/2026

Employee stock option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

6.50K shares

Shares

6.50K

Strike price

20.46

Held after

19.50K

Exercisable

4/14/2026
CALVIN SANDRA — Insider Transaction (Form 4) Filed Apr 16, 2026 | Finecho